Organon Pharma Indonesia PT (ISX:SCPI) Long-Term Capital Lease Obligation : Rp0.00 Mil (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Long-Term Capital Lease Obligation?

Organon Pharma Indonesia PT's Long-Term Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil.

Organon Pharma Indonesia PT Long-Term Capital Lease Obligation Historical Data

The historical data trend for Organon Pharma Indonesia PT's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Long-Term Capital Lease Obligation Chart

Organon Pharma Indonesia PT Annual Data

Trend

Long-Term Capital Lease Obligation

Organon Pharma Indonesia PT Quarterly Data

Long-Term Capital Lease Obligation

Organon Pharma Indonesia PT (ISX:SCPI) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Organon Pharma Indonesia PT Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920

Website

https://www.organon.com/indonesia

Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines